发明名称 |
Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
摘要 |
This invention relates to methods of treating traumatic brain injury (TBI) or hypoxic or ischemic stroke, comprising administering to a patient in need of such treatment an NR2B subtype selective N-methyl-D-aspartate (NMDA) receptor antagonist in combination with either: (a) a neutrophil inhibitory factor (NIF); (b) a sodium channel antagonist; (c) a nitric oxide synthase (NOS) inhibitor; (d) a glycine site antagonist; (e) a potassium channel opener; (f) an AMPA/kainate receptor antagonist; (g) a calcium channel antagonist; (h) a GABA-A receptor modulator (e.g., a GABA-A receptor agonist); or (i) an antiinflammatory agent.
|
申请公布号 |
US2002045656(A1) |
申请公布日期 |
2002.04.18 |
申请号 |
US20010947652 |
申请日期 |
2001.09.06 |
申请人 |
CHENARD BERTRAND L.;MENNITI FRANK S.;SALTARELLI MARIO D. |
发明人 |
CHENARD BERTRAND L.;MENNITI FRANK S.;SALTARELLI MARIO D. |
分类号 |
A61K45/06;A61K31/05;A61K31/075;A61K31/353;A61K31/40;A61K31/435;A61K31/445;A61K31/451;A61K31/453;A61P9/00;A61P9/10;A61P43/00;(IPC1-7):A61K31/353 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|